Polaris Intl Hldgs (PIHN) 0.0037 $PIHN
Polaris International Holdings, Inc. to Release Energy Drink Shot
Marketwire - Wed May 28, 8:06AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce it has reached an agreement with a Dallas based manufacturer to produce a proprietary energy drink shot product as part of its hemp based nutraceutical supplement line. The energy drink shot will be the 3rd nutraceutical product of the Company to go along with its hemp protein powder and brain health supplements.
Polaris International Holdings, Inc., to Release Brain Health Supplement
Marketwire - Wed May 21, 10:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line. The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.
Polaris International Holdings, Inc., to Release Brain Health Supplement nt
eTeligis - Wed May 21, 10:30AM CDT
PLANO, TX, United States, via eTeligis Inc., 05/21/2014 - - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line.The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.
Polaris International Holdings, Inc. to Launch Nutraceutical Line of Products
Marketwire - Fri May 16, 8:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) will be launching a new hemp-based nutraceutical supplement line in the Fall of 2014. The Company's first product will be a new proprietary blend hemp protein powder. The initial flavors of the product will be chocolate, vanilla, and strawberry.
Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed on Kentucky Farm
Marketwire - Thu May 01, 7:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.
Cannabis Sector Appears To Stabilize With New Advancements - Company Enters JV for 70 Acre Hemp Farm
PR Newswire - Tue Apr 22, 8:02AM CDT
Marijuana companies acquire resources with expansion in sight: Polaris International Holdings, Inc. (OTC: PIHN), Tranzbyte Corporation (OTC: ERBB), Planda (OTC: PLPL), Nuvilex, Inc. (OTC: NVLX), Latteno Food Corp. (OTC: LATF) and MediSwipe, Inc. (OTC: MWIP)
Polaris International Holdings Enters Joint Venture for Kentucky Hemp Project
PR Newswire - Tue Apr 22, 7:00AM CDT
Polaris International Holdings, Inc. (OTC: PIHN) has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.
PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
Marketwire - Wed Apr 09, 6:20AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.
PIHN Announces Procannas' Cannabinoid Transdermal Product Development
Marketwire - Mon Apr 07, 6:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, has begun development of a unique and proprietary transdermal patch capable of delivering cannabinoids directly through the skin. This hallmark solution is intended to address a significant, unmet need for individuals requiring long-term, time released delivery. The Company believes, subject to testing and trials to be initiated by our participating physicians, that the patch may able to deliver cannabinoids for up to 48 hours. The Company further expects that this mechanism of delivery could revolutionize the way cannabinoids are introduced into the blood stream minimizing the negative effects on lungs and other organs commonly seen in other delivery methods. The Company expects to be ready to begin trials in 90 days.
PIHN Hires New Medical Director to Start International Clinical Trials
Marketwire - Tue Apr 01, 5:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce the Company has added Dr. Vasthi Alvarez Avila as Medical Director and to the Corporate Board of Directors. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.
Polaris International Holdings Signs Agreement With India Based Affiliates and Secures New Offices
Marketwire - Thu Mar 20, 7:46AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it has completed an important agreement with GBISS, Inc. and its India based affiliates to begin project management and manufacturing of the Company's exclusive Procannas(R) Cannatrol pharmaceutical grade core ingredients and sub-formulations.
PIHN Signs Exclusive Rights to ProCannas(R) Cannabinoid Line
Marketwire - Wed Mar 19, 6:15AM CDT
Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas(R) product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas(R) line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas(R) Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.
Polaris International Holdings, Inc. to Release Energy Drink Shot
Marketwire - Wed May 28, 8:06AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce it has reached an agreement with a Dallas based manufacturer to produce a proprietary energy drink shot product as part of its hemp based nutraceutical supplement line. The energy drink shot will be the 3rd nutraceutical product of the Company to go along with its hemp protein powder and brain health supplements.
Polaris International Holdings, Inc., to Release Brain Health Supplement
Marketwire - Wed May 21, 10:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line. The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.
Polaris International Holdings, Inc., to Release Brain Health Supplement nt
eTeligis - Wed May 21, 10:30AM CDT
PLANO, TX, United States, via eTeligis Inc., 05/21/2014 - - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line.The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements.
Polaris International Holdings, Inc. to Launch Nutraceutical Line of Products
Marketwire - Fri May 16, 8:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) will be launching a new hemp-based nutraceutical supplement line in the Fall of 2014. The Company's first product will be a new proprietary blend hemp protein powder. The initial flavors of the product will be chocolate, vanilla, and strawberry.
Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed on Kentucky Farm
Marketwire - Thu May 01, 7:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased over 2,000 lbs of hemp seed to plant on the 70 acre farm in Kentucky. The Company plans on planting the seeds on May 24 and 25, 2014, with the help of several area Military Veterans. This event should receive significant media coverage throughout the area.
Cannabis Sector Appears To Stabilize With New Advancements - Company Enters JV for 70 Acre Hemp Farm
PR Newswire - Tue Apr 22, 8:02AM CDT
Marijuana companies acquire resources with expansion in sight: Polaris International Holdings, Inc. (OTC: PIHN), Tranzbyte Corporation (OTC: ERBB), Planda (OTC: PLPL), Nuvilex, Inc. (OTC: NVLX), Latteno Food Corp. (OTC: LATF) and MediSwipe, Inc. (OTC: MWIP)
Polaris International Holdings Enters Joint Venture for Kentucky Hemp Project
PR Newswire - Tue Apr 22, 7:00AM CDT
Polaris International Holdings, Inc. (OTC: PIHN) has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.
PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
Marketwire - Wed Apr 09, 6:20AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.
PIHN Announces Procannas' Cannabinoid Transdermal Product Development
Marketwire - Mon Apr 07, 6:15AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, has begun development of a unique and proprietary transdermal patch capable of delivering cannabinoids directly through the skin. This hallmark solution is intended to address a significant, unmet need for individuals requiring long-term, time released delivery. The Company believes, subject to testing and trials to be initiated by our participating physicians, that the patch may able to deliver cannabinoids for up to 48 hours. The Company further expects that this mechanism of delivery could revolutionize the way cannabinoids are introduced into the blood stream minimizing the negative effects on lungs and other organs commonly seen in other delivery methods. The Company expects to be ready to begin trials in 90 days.
PIHN Hires New Medical Director to Start International Clinical Trials
Marketwire - Tue Apr 01, 5:45AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce the Company has added Dr. Vasthi Alvarez Avila as Medical Director and to the Corporate Board of Directors. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.
Polaris International Holdings Signs Agreement With India Based Affiliates and Secures New Offices
Marketwire - Thu Mar 20, 7:46AM CDT
Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it has completed an important agreement with GBISS, Inc. and its India based affiliates to begin project management and manufacturing of the Company's exclusive Procannas(R) Cannatrol pharmaceutical grade core ingredients and sub-formulations.
PIHN Signs Exclusive Rights to ProCannas(R) Cannabinoid Line
Marketwire - Wed Mar 19, 6:15AM CDT
Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas(R) product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas(R) line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas(R) Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.
